Reply to comment on: Incidence and predictors of postoperative delirium after cytoreduction surgery-hyperthermic intraperitoneal chemotherapy

Affiliations

¹ Department of Surgical Oncology, University Medical Center Groningen, University of Groningen, Groningen, The Netherlands.
² Department of Epidemiology, University Medical Center Groningen, University of Groningen, Groningen, The Netherlands.

Comment

Matthijs Plas et al. J Surg Oncol. 2018 Mar.

. 2018 Mar;117(4):808.

doi: 10.1002/jso.24914. Epub 2017 Dec 11.

¹ Department of Surgical Oncology, University Medical Center Groningen, University of Groningen, Groningen, The Netherlands.
² Department of Epidemiology, University Medical Center Groningen, University of Groningen, Groningen, The Netherlands.

No abstract available

Comment on

Incidence and predictors of postoperative delirium after cytoreduction surgery-hyperthermic intraperitoneal chemotherapy.
Plas M, Hemmer PHJ, Been LB, van Ginkel RJ, de Bock GH, van Leeuwen BL. Plas M, et al. J Surg Oncol. 2018 Feb;117(2):260-268. doi: 10.1002/jso.24811. Epub 2017 Sep 20. J Surg Oncol. 2018. PMID: 28940461
Incidence and predictors of postoperative delirium after cytoreduction surgery-hyperthermic intraperitoneal chemotherapy: Methodological issues.
Weng J, Wu H, Wang Z. Weng J, et al. J Surg Oncol. 2018 Mar;117(4):807. doi: 10.1002/jso.24915. Epub 2017 Dec 11. J Surg Oncol. 2018. PMID: 29228464 No abstract available.